New Enterprise Associates 17, L.P. Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

New Enterprise Associates 17, L.P. is > 10% Shareholder of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 7.69 Million shares of GLUE, which is worth approximately $54.9 Million. The most recent transaction as insider was on Jun 28, 2021, when has been sold 1,050,000 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $19,950,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.69M

0% 3M change

0% 12M change

Total Value Held $54.9 Million

New Enterprise Associates 17, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 28 2021	BUY Open market or private purchase	$19,950,000 $19.0 p/Share	1,050,000 Added 12.01%	7,692,298 Common Stock
Jun 28 2021	BUY Conversion of derivative security	-	6,642,298 Added 50.0%	6,642,298 Common Stock

Also insider at

BHG

Bright Health Group Inc. Healthcare

FREQ

Frequency Therapeutics, Inc. Healthcare

MBX

MBX Biosciences, Inc.

NEA